)
Halozyme Therapeutics (HALO) investor relations material
Halozyme Therapeutics AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Opening remarks and agenda
Meeting called to order with voting and Q&A instructions provided to shareholders.
Mark Snyder appointed as secretary and Inspector of Elections; board members and auditors introduced.
Quorum established with 104.1 million shares represented, authorizing business transactions.
Agenda included election of two Class I directors, advisory vote on executive compensation, and ratification of the auditor.
Board and executive committee updates
Bernadette Connaughton and Matthew Posard elected as Class I directors for a three-year term.
Special thanks extended to outgoing board member Moni Miyashita for her contributions.
Shareholder proposals
Advisory vote approved executive compensation.
Ratification of Ernst & Young LLP as independent auditor for fiscal year ending December 31, 2026.
- Director elections, executive pay, and auditor ratification headline the May 2026 meeting.HALO
Proxy filing23 Mar 2026 - 2026 proxy covers director elections, say-on-pay, auditor ratification, and record 2025 performance.HALO
Proxy filing23 Mar 2026 - Strong royalty-driven growth, pipeline expansion, and new technologies fuel long-term outlook.HALO
The Citizens Life Sciences Conference 202611 Mar 2026 - Acquisitions and innovation drive pipeline growth and subcutaneous delivery expansion.HALO
Leerink Global Healthcare Conference 202610 Mar 2026 - Acquisitions and innovation in sub-Q delivery drive growth, with strong royalty outlook and minimal Medicare risk.HALO
TD Cowen 46th Annual Health Care Conference3 Mar 2026 - Record revenue and strong 2026 outlook fueled by ENHANZE royalties and acquisitions.HALO
Q4 202517 Feb 2026 - Q2 2025 saw record revenue, earnings, and guidance increases on robust royalty and product growth.HALO
Q2 20253 Feb 2026 - Raised 2026 guidance and expanded SC delivery platforms, projecting durable growth.HALO
Investor update3 Feb 2026 - Q2 2024 delivered strong revenue and royalty growth, new product approvals, and robust guidance.HALO
Q2 20242 Feb 2026
Next Halozyme Therapeutics earnings date
Next Halozyme Therapeutics earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)